Pre-Conference Workshops
- Strategic regulatory pivot: European Commission's shift from authorisation-based frameworks to restriction-focused regulation.
- The latest intelligence on the delayed REACH revision (now expected second half of 2026 following Regulatory Scrutiny Board rejection in September 2025)
- What this strategic recalibration means for manufacturers navigating the transition; from established compliance pathways to emerging restriction paradigms.
- Key elements of the REACH revision & what is changing
- Industry impact: continuous dossier compliance, data strategy, and supply chain digitalisation
- Risk management and enforcement: what may change for registrants and downstream users in practice.
- Polymers: expected framework direction
- What a workable transition would look like: impact assessment expectations, proportionality, and burden control
- Matteo Dalla Valle, Ph.D. - Global Product Stewardship Manager, Chevron Oronite S.A.S.
- Deregulation promise: The Omnibus VI package offers streamlined registration procedures and accelerated innovation pathways.
- Strategically leveraging simplification measures whilst maintaining robust compliance frameworks.
- An outline of the administrative burdens genuinely disappearing.
- "Stop the Clock" relief offers breathing room, but core classification obligations remain on the original timeline.
- Digital labelling opportunities as more than technological convenience—signalling a shift in how regulatory information flows through supply chains
- The selective postponement strategy reveals which requirements regulators consider negotiable versus non-negotiable in the safety framework
- How CLP changes interact with the REACH revision; a holistic approach.
- Key aspects: Positive list system and mandatory certification.
- ECHA's central role in managing the positive list
- The directive's significance – a compliance model that could migrate to other regulatory frameworks
- Chemical producers, manufacturers and notified bodies face a learning curve in navigating unfamiliar certification requirements.
- Impact on cosmetics
- Explanation of the positive list for starting substances.
- Process for getting substances approved and added to the list.
- Role of ECHA in data generation and registration.
- Challenges faced by chemical producers and intermediate product manufacturers.
- Mandatory certification process for final products and production processes.
- Role of notified bodies in assessing products and conducting audits; how third-party verification impacts cost, efficiency, and market access.
- Differences between DWD certification and self-certification in other regulations.
- Practical steps for manufacturers to comply with certification requirements.
- Regulatory divergence reality: Extended UK deadlines create strategic opportunities for companies operating in both markets, but dual compliance burdens threaten to fragment supply chains
- Can businesses sustain parallel compliance systems indefinitely?
- How to strategically position portfolios to leverage divergence advantages whilst mitigating the risks of regulatory fragmentation
- The compliance deadline hammer: With enforcement effective in August, what is the impact of these stringent restrictions?
- Emission limits across furniture, construction, textiles, and automotive sectors force fundamental reformulation decisions.
- Supply chain verification becomes the critical variable.
- Regulatory credibility crisis: unpacking the tension between proposed measures and their assessed impacts.
- With strategic planning demanding clarity, are we still staring down the barrel of uncertainty?
- The restriction that changes everything: Analysing the impact and status of the universal PFAS restriction.
- Sector-specific impacts revealing impossible trade-offs regulators face—from packaging to firefighting foams, every use case presents unique safety versus functionality dilemmas.
Brief summary of action items and compliance priorities for attendees.
- Regulatory intersection complexity: DWD's interaction with REACH, biocides, and CLP creates compliance scenarios where meeting one regulation's requirements may conflict with another's
- Biocide use in DWD materials faces specific restrictions
- Additional labelling requirements beyond CLP
- The cosmetics and pharmaceuticals overlap through wastewater directives.
Supply chain transparency imperative: Notified bodies' need to verify starting substances in mixtures forces unprecedented disclosure of proprietary formulation information
Lack of awareness around DWD requirements suggests many companies will face compliance crises they didn't anticipate
Strategic approaches to streamline certification processes must balance efficiency with the thoroughness notified bodies will demand
The invisible contamination challenge: metabolites that don't appear on any positive list but emerge through transformation processes in water systems
Identifying and assessing metabolites; the analytical and toxicological expertise required.
Unclear public health implications of metabolite presence creates regulatory uncertainty around acceptable exposure levels
Monitoring and mitigation strategies that address substances formed unpredictably from approved starting materials
Anticipating regulatory evolution: Whether DWD requirements will expand or contract over time depends on implementation experience.
Revealing the knowledge gaps that currently exists across the industry.
Collaboration with trade associations offers opportunities to shape how DWD implementation unfolds.
Brief summary of action items and compliance priorities for attendees.
